ventoline nebules 2.5mg
glaxosmithkline s.a (pty) ltd - salbutamol sulphate - solution for inhalation - each 2.5ml ampoules contain salbutamol sulphate equiv. to salbutamol 2.5mg
ventoline nebules 5mg
glaxosmithkline s.a (pty) ltd - salbutamol sulphate - solution for inhalation - each 2.5ml ampoules contain salbutamol sulphate equiv. to salbutamol 5mg
gardette 160 mikrogram/4,5 mikrogram/inhalation inhalationsspray, suspension
symbicort 160 mikrogram/4,5 mikrogram/puff inhalationsspray, suspension
airsalb 0,1 mg/dos inhalationsspray, suspension
sabumalin 100 mikrogram/dos inhalationsspray, suspension
salbutamol sandoz 100 mikrogram/dos inhalationsspray, suspension
sanohex 100 mikrogram/dos inhalationsspray, suspension
ventolin oral liquid
glaxosmithkline inc - salbutamol (salbutamol sulfate) - liquid - 0.4mg - salbutamol (salbutamol sulfate) 0.4mg - selective beta 2-adrenergic agonists
ventolin inhaler cfc-free salbutamol 100 microgram (as sulfate) pressurised inhaler metered dose
glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 120.5 microgram/actuation (equivalent: salbutamol, qty 100 microgram/actuation) - inhalation, pressurised - excipient ingredients: norflurane - other conditions: do not puncture or incinerate even when empty as canister may explode. indications: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma and other stimuli known to induce bronchospasm.